Search research articles
Contact Us
Filters
Showing results (161-170 of 299) with videos related to
Page
of 30
Sort By:
Muscle & Nerve
|
June 17, 1998
Normal postexercise facilitation and depression of motor evoked potentials in postpolio patients
A Samii, J Lopez-Devine, E M Wasserman, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
Mita Kuchimanchi, Anita Grover, Maurice G Emery, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
Dick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Neuropharmacology
|
September 22, 2018
Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury
Meghan O Blaya, Joseph M Wasserman, Andrew A Pieper, et al.
Child Psychiatry and Human Development
|
October 17, 2020
The Development of Externalizing and Internalizing Behaviors Among Youth With or Without a Family History of Substance Use Disorder: The Indirect Effects of Early-Life Stress and Impulsivity
A M Wasserman, J Wimmer, N Hill-Kapturczak, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 9, 2019
Text-message responsiveness to blood glucose monitoring reminders is associated with HbA<sub>1c</sub> benefit in teenagers with Type 1 diabetes
D E McGill, L K Volkening, D A Butler, et al.
Clinical Pharmacokinetics
|
January 22, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
Sreeneeranj Kasichayanula, Anita Grover, Maurice G Emery, et al.
The Journal of Biological Chemistry
|
July 6, 2004
A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones
Bo-Tsung Wu, Yueh-Hsing Su, Ming-Tzu Tsai, et al.
Circulation Research
|
August 1, 2015
Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study
Dirk J Blom, C Stephen Djedjos, Maria Laura Monsalvo, et al.
Journal of Lipid Research
|
October 7, 2016
Effect of evolocumab on cholesterol synthesis and absorption
Matthew Peach, Ren Xu, Dan Fitzpatrick, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 299) with videos related to
Sort By:
Page
of 30
Muscle & Nerve
|
June 17, 1998
Normal postexercise facilitation and depression of motor evoked potentials in postpolio patients
A Samii, J Lopez-Devine, E M Wasserman, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia
Mita Kuchimanchi, Anita Grover, Maurice G Emery, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
Dick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Neuropharmacology
|
September 22, 2018
Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury
Meghan O Blaya, Joseph M Wasserman, Andrew A Pieper, et al.
Child Psychiatry and Human Development
|
October 17, 2020
The Development of Externalizing and Internalizing Behaviors Among Youth With or Without a Family History of Substance Use Disorder: The Indirect Effects of Early-Life Stress and Impulsivity
A M Wasserman, J Wimmer, N Hill-Kapturczak, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 9, 2019
Text-message responsiveness to blood glucose monitoring reminders is associated with HbA<sub>1c</sub> benefit in teenagers with Type 1 diabetes
D E McGill, L K Volkening, D A Butler, et al.
Clinical Pharmacokinetics
|
January 22, 2018
Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor
Sreeneeranj Kasichayanula, Anita Grover, Maurice G Emery, et al.
The Journal of Biological Chemistry
|
July 6, 2004
A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones
Bo-Tsung Wu, Yueh-Hsing Su, Ming-Tzu Tsai, et al.
Circulation Research
|
August 1, 2015
Effects of Evolocumab on Vitamin E and Steroid Hormone Levels: Results From the 52-Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled DESCARTES Study
Dirk J Blom, C Stephen Djedjos, Maria Laura Monsalvo, et al.
Journal of Lipid Research
|
October 7, 2016
Effect of evolocumab on cholesterol synthesis and absorption
Matthew Peach, Ren Xu, Dan Fitzpatrick, et al.
Page
of 30